Work

Vitamin E and Oxidative Stress Modulation in the Treatment of Non-alcoholic Fatty Liver Disease: Current Evidence and Clinical Perspectives

Year: 2026

Type: article

Abstract: Non-alcoholic fatty liver disease (NAFLD), recently reclassified as metabolic dysfunction-associated steatotic liver disease (MASLD), encompasses a spectrum from simple steatosis to non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular carcinoma. It is strongly associated with metabolic syndrome, obesity, and insulin resistance.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.20441714

Author: 1*Shaik Ahammad, 1J. M. V. Lakshmi, 1Panchananam Lekhana, 2Dr. T. Sharath Babu

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7162765596

FWCI:

Cites:

Cited by:

Related to: